These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33324682)

  • 1. Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment.
    Wu Z; Zhang Y; Chen X; Tan W; He L; Peng L
    Front Mol Biosci; 2020; 7():601206. PubMed ID: 33324682
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values.
    Hu LT; Deng WJ; Chu ZS; Sun L; Zhang CB; Lu SZ; Weng JR; Ren QS; Dong XY; Li WD; Li XB; Du YT; Li Y; Wang WQ
    BMC Pulm Med; 2022 Jun; 22(1):259. PubMed ID: 35768814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
    Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
    Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
    Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
    Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.
    Zhang C; Cui Y; Wang G; Zhao W; Zhao H; Huang X; Zhang M; Li W
    J Healthc Eng; 2021; 2021():5790416. PubMed ID: 34531966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the prognostic values of CXCR family in gastric cancer.
    Yu C; Zhang Y
    Cytokine; 2019 Nov; 123():154785. PubMed ID: 31344595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis.
    Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
    Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
    Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
    Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the prognostic value of
    Chen J; Ye Z; Liu L; Xuan B
    Transl Androl Urol; 2022 Apr; 11(4):509-518. PubMed ID: 35558273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of sirtuin family members and experimental verification identify SIRT5 as diagnostic biomarkers in clear cell renal cell carcinoma.
    Peng LS; Duan SL; Li RQ; Bai ZY; Ou CL; Wang JP
    PeerJ; 2023; 11():e15154. PubMed ID: 37096064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma.
    Guo H; Jiang S; Sun H; Shi B; Li Y; Zhou N; Zhang D; Guo H
    Dis Markers; 2022; 2022():9443407. PubMed ID: 35299868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of MAP3K8 on Prognosis and Tumor-Related Inflammation in Renal Clear Cell Carcinoma.
    Hao J; Cao Y; Yu H; Zong L; An R; Xue Y
    Front Genet; 2021; 12():674613. PubMed ID: 34567061
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma.
    Shen Y; Zhou C; Cao Y; Li Q; Deng H; Gu S; Wu Y; Shen Z
    World J Surg Oncol; 2022 Aug; 20(1):259. PubMed ID: 35978426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma.
    Zhu Y; Pu Z; Li Z; Lin Y; Li N; Peng F
    Front Oncol; 2021; 11():700528. PubMed ID: 34395271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive exploration of the expression and prognostic value of AQPs in clear cell renal cell carcinoma.
    Wang H; Zhang W; Ding Z; Xu T; Zhang X; Xu K
    Medicine (Baltimore); 2022 Oct; 101(41):e29344. PubMed ID: 36254092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma.
    Nie W; Yao Y; Luo B; Zhu J; Li S; Yang X; Luo T; Liu W; Yan S
    Front Oncol; 2022; 12():755936. PubMed ID: 35372055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.
    Sun Y; Yang M; Zhang Q
    Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSDMB: A novel, independent prognostic marker and potential new therapeutic target in clear cell renal cell carcinoma.
    Huang H; Chen R; Deng X; Wang J; Chen J
    Oncol Lett; 2024 Feb; 27(2):85. PubMed ID: 38249806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression and the significant prognostic value of aquaporins in clear cell renal cell carcinoma.
    Li M; He M; Xu F; Guan Y; Tian J; Wan Z; Zhou H; Gao M; Chong T
    PLoS One; 2022; 17(3):e0264553. PubMed ID: 35245343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
    Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
    Front Genet; 2020; 11():810. PubMed ID: 33014010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.